Table 3 Marginal means, confidence intervals, effect sizes, and results of linear mixed models analyses

Measure and Assessment Point

Mean

SD

95% CI

Mean

SD

95% CI

d^a

B

95% CI

d^b

Global Severity Index (SCL-90-R)

−0.30

−0.50,-0.08

0.77**

 Pre-treatment

1.06

0.59

0.87,1.26

1.02

0.59

0.83,1.22

 Post-treatment

0.67

0.55

0.47,0.87

0.93

0.51

0.71,1.14

0.48

Depression (SCL-90-R)

−0.46

−0.82,-0.09

0.68*

 Pre-treatment

1.57

0.85

1.29,1.85

1.60

0.85

1.32,1.88

 Post-treatment

0.94

0.80

0.65,1.24

1.43

0.76

1.11,1.76

0.63*

Anxiety (SCL-90-R)^c

−0.22

−0.36,-0.08

0.87**

 Pre-treatment

0.60

0.35

0.49,0.72

0.56

0.35

0.44,0.67

 Post-treatment

0.36

0.33

0.24,0.48

0.53

0.31

0.40,0.67

0.53

Sleep Quality (PSQI)

−2.94

−4.68,-1.19

0.88**

 Pre-treatment

9.67

3.31

8.57,10.76

8.67

3.29

7.57,9.77

 Post-treatment

6.47

3.21

5.29,7.65

8.41

3.12

7.09,9.73

0.61*

Exercise (BSA questionnaire)^c

2.51

1.41,3.61

0.82***

 Pre-treatment

1.82

1.82

1.22,2.42

1.72

1.82

1.12,2.33

 week 9

4.68

1.80

4.00,5.35

1.74

1.79

1.04,2.45

1.64***

 Post-treatment

4.12

1.80

3.46,4.78

1.53

1.77

0.78,2.27

1.45***

Depression (single and with comorbid anxiety disorders) (SCL-90-R)^d

−0.55

−1.01,−0.09

0.78*

 Pre-treatment

1.84

0.79

1.51,2.17

2.00

0.78

1.68,2.32

 Post-treatment

1.10

0.77

0.77,1.44

1.81

0.71

1.42,2.20

0.95**